Incidence and risk of fatal adverse events in cancer patients treated with HER2-targeted antibody-drug conjugates: a systematic review and meta-analysis of randomized controlled trials

被引：0
作者：
Zhiwen Fu
Chen Gao
Jiyi Xie
Cong Zhang
Shijun Li
Ming Gu
Chen Shi
机构：
[1] Huazhong University of Science and Technology,Department of Pharmacy, Union Hospital, Tongji Medical College
[2] Hubei Province Clinical Research Center for Precision Medicine for Critical Illness,undefined
来源：
BMC Cancer | / 23卷 / 1期
关键词：
HER2-targeted ADC; Fatal adverse events; Incidence and risk; Systematic review; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 38 条
  • [31] Harbord RM(2023)Mechanisms of ADC toxicity and strategies to increase ADC tolerability Cancers 15 713-undefined
  • [32] Menderes G(2019)Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates Pharmacol Ther 200 110-undefined
  • [33] Ma B(undefined)undefined undefined undefined undefined-undefined
  • [34] Zhu Y(undefined)undefined undefined undefined undefined-undefined
  • [35] Nguyen TD(undefined)undefined undefined undefined undefined-undefined
  • [36] Bordeau BM(undefined)undefined undefined undefined undefined-undefined
  • [37] Balthasar JP(undefined)undefined undefined undefined undefined-undefined
  • [38] Mahalingaiah PK(undefined)undefined undefined undefined undefined-undefined
1234